Technical feasibility and oncological outcomes of robotic esophagectomy compared with conventional thoracoscopic esophagectomy for clinical T3 or T4 locally advanced esophageal cancer: a propensity-matched analysis

go back to reference Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, Kopp HG, Mayer F, Haag GM, Luley K, Lindig U, Schmiegel W, Pohl M, Stoehlmacher J, Folprecht G, Probst S, Prasnikar N, Fischbach W, Mahlberg R, Trojan J, Koenigsmann M, Martens UM, Thuss-Patience P, Egger M, Block A, Heinemann V, Illerhaus G, Moehler M, Schenk M, Kullmann F, Behringer DM, Heike M, Pink D, Teschendorf C, Löhr C, Bernhard H, Schuch G, Rethwisch V, von Weikersthal LF, Hartmann JT, Kneba M, Daum S, Schulmann K, Weniger J, Belle S, Gaiser T, Oduncu FS, Güntner M, Hozaeel W, Reichart A, Jäger E, Kraus T, Mönig S, Bechstein WO, Schuler M, Schmalenberg H, Hofheinz RD (2019) Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet 393:1948–1957CrossRefPubMed Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, Kopp HG, Mayer F, Haag GM, Luley K, Lindig U, Schmiegel W, Pohl M, Stoehlmacher J, Folprecht G, Probst S, Prasnikar N, Fischbach W, Mahlberg R, Trojan J, Koenigsmann M, Martens UM, Thuss-Patience P, Egger M, Block A, Heinemann V, Illerhaus G, Moehler M, Schenk M, Kullmann F, Behringer DM, Heike M, Pink D, Teschendorf C, Löhr C, Bernhard H, Schuch G, Rethwisch V, von Weikersthal LF, Hartmann JT, Kneba M, Daum S, Schulmann K, Weniger J, Belle S, Gaiser T, Oduncu FS, Güntner M, Hozaeel W, Reichart A, Jäger E, Kraus T, Mönig S, Bechstein WO, Schuler M, Schmalenberg H, Hofheinz RD (2019) Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet 393:1948–1957CrossRefPubMed

go back to reference Shapiro J, van Lanschot JJB, Hulshof M, van Hagen P, van Berge Henegouwen MI, Wijnhoven BPL, van Laarhoven HWM, Nieuwenhuijzen GAP, Hospers GAP, Bonenkamp JJ, Cuesta MA, Blaisse RJB, Busch ORC, Ten Kate FJW, Creemers GM, Punt CJA, Plukker JTM, Verheul HMW, Bilgen EJS, van Dekken H, van der Sangen MJC, Rozema T, Biermann K, Beukema JC, Piet AHM, van Rij CM, Reinders JG, Tilanus HW, Steyerberg EW, van der Gaast A (2015) Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 16:1090–1098CrossRefPubMed Shapiro J, van Lanschot JJB, Hulshof M, van Hagen P, van Berge Henegouwen MI, Wijnhoven BPL, van Laarhoven HWM, Nieuwenhuijzen GAP, Hospers GAP, Bonenkamp JJ, Cuesta MA, Blaisse RJB, Busch ORC, Ten Kate FJW, Creemers GM, Punt CJA, Plukker JTM, Verheul HMW, Bilgen EJS, van Dekken H, van der Sangen MJC, Rozema T, Biermann K, Beukema JC, Piet AHM, van Rij CM, Reinders JG, Tilanus HW, Steyerberg EW, van der Gaast A (2015) Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 16:1090–1098CrossRefPubMed

go back to reference Kato K, Ito Y, Daiko H, Ozawa S, Ogata T, Hara H, Kojima T, Abe T, Bamba T, Watanabe M, Kawakubo H, Shibuya Y, Tsubosa Y, Takegawa N, Kajiwara T, Baba H, Ueno M, Machida R, Nakamura K, Kitagawa Y (2022) A randomized controlled phase III trial comparing two chemotherapy regimen and chemoradiotherapy regimen as neoadjuvant treatment for locally advanced esophageal cancer, JCOG1109 NExT study. J Clin Oncol 40:238–238CrossRef Kato K, Ito Y, Daiko H, Ozawa S, Ogata T, Hara H, Kojima T, Abe T, Bamba T, Watanabe M, Kawakubo H, Shibuya Y, Tsubosa Y, Takegawa N, Kajiwara T, Baba H, Ueno M, Machida R, Nakamura K, Kitagawa Y (2022) A randomized controlled phase III trial comparing two chemotherapy regimen and chemoradiotherapy regimen as neoadjuvant treatment for locally advanced esophageal cancer, JCOG1109 NExT study. J Clin Oncol 40:238–238CrossRef

go back to reference Kelly RJ, Ajani JA, Kuzdzal J, Zander T, Van Cutsem E, Piessen G, Mendez G, Feliciano J, Motoyama S, Lièvre A, Uronis H, Elimova E, Grootscholten C, Geboes K, Zafar S, Snow S, Ko AH, Feeney K, Schenker M, Kocon P, Zhang J, Zhu L, Lei M, Singh P, Kondo K, Cleary JM, Moehler M (2021) Adjuvant Nivolumab in resected esophageal or gastroesophageal junction cancer. N Engl J Med 384:1191–1203CrossRefPubMed Kelly RJ, Ajani JA, Kuzdzal J, Zander T, Van Cutsem E, Piessen G, Mendez G, Feliciano J, Motoyama S, Lièvre A, Uronis H, Elimova E, Grootscholten C, Geboes K, Zafar S, Snow S, Ko AH, Feeney K, Schenker M, Kocon P, Zhang J, Zhu L, Lei M, Singh P, Kondo K, Cleary JM, Moehler M (2021) Adjuvant Nivolumab in resected esophageal or gastroesophageal junction cancer. N Engl J Med 384:1191–1203CrossRefPubMed

go back to reference Yamashita K, Watanabe M, Mine S, Toihata T, Fukudome I, Okamura A, Yuda M, Hayami M, Ishizuka N, Imamura Y (2018) Minimally invasive esophagectomy attenuates the postoperative inflammatory response and improves survival compared with open esophagectomy in patients with esophageal cancer: a propensity score matched analysis. Surg Endosc 32:4443–4450CrossRefPubMed Yamashita K, Watanabe M, Mine S, Toihata T, Fukudome I, Okamura A, Yuda M, Hayami M, Ishizuka N, Imamura Y (2018) Minimally invasive esophagectomy attenuates the postoperative inflammatory response and improves survival compared with open esophagectomy in patients with esophageal cancer: a propensity score matched analysis. Surg Endosc 32:4443–4450CrossRefPubMed

go back to reference Kalff MC, Fransen LFC, de Groot EM, Gisbertz SS, Nieuwenhuijzen GAP, Ruurda JP, Verhoeven RHA, Luyer MDP, van Hillegersberg R, van Berge Henegouwen MI (2022) Long-term survival after minimally invasive versus open esophagectomy for esophageal cancer: a nationwide propensity-score matched analysis. Ann Surg 276:e749–e757CrossRefPubMed Kalff MC, Fransen LFC, de Groot EM, Gisbertz SS, Nieuwenhuijzen GAP, Ruurda JP, Verhoeven RHA, Luyer MDP, van Hillegersberg R, van Berge Henegouwen MI (2022) Long-term survival after minimally invasive versus open esophagectomy for esophageal cancer: a nationwide propensity-score matched analysis. Ann Surg 276:e749–e757CrossRefPubMed

go back to reference Kubo K, Kanematsu K, Kurita D, Ishiyama K, Oguma J, Itami J, Daiko H (2021) Feasibility of conversion thoracoscopic esophagectomy after induction therapy for locally advanced unresectable esophageal squamous cell carcinoma. Jpn J Clin Oncol 51:1225–1231CrossRefPubMed Kubo K, Kanematsu K, Kurita D, Ishiyama K, Oguma J, Itami J, Daiko H (2021) Feasibility of conversion thoracoscopic esophagectomy after induction therapy for locally advanced unresectable esophageal squamous cell carcinoma. Jpn J Clin Oncol 51:1225–1231CrossRefPubMed

go back to reference Ishiyama K, Oguma J, Kubo K, Kanematsu K, Kurita D, Daiko H (2022) Salvage minimally invasive esophagectomy after definitive chemoradiotherapy for esophageal cancer can improve postoperative complications compared with salvage open esophagectomy. Surg Endosc 36:3504–3510CrossRefPubMed Ishiyama K, Oguma J, Kubo K, Kanematsu K, Kurita D, Daiko H (2022) Salvage minimally invasive esophagectomy after definitive chemoradiotherapy for esophageal cancer can improve postoperative complications compared with salvage open esophagectomy. Surg Endosc 36:3504–3510CrossRefPubMed

go back to reference Daiko H, Oguma J, Fujiwara H, Ishiyama K, Kurita D, Sato K, Fujita T (2021) Robotic esophagectomy with total mediastinal lymphadenectomy using four robotic arms alone in esophageal and esophagogastric cancer (RETML-4): a prospective feasibility study. Esophagus 18:203–210CrossRefPubMed Daiko H, Oguma J, Fujiwara H, Ishiyama K, Kurita D, Sato K, Fujita T (2021) Robotic esophagectomy with total mediastinal lymphadenectomy using four robotic arms alone in esophageal and esophagogastric cancer (RETML-4): a prospective feasibility study. Esophagus 18:203–210CrossRefPubMed

go back to reference Mederos MA, de Virgilio MJ, Shenoy R, Ye L, Toste PA, Mak SS, Booth MS, Begashaw MM, Wilson M, Gunnar W, Shekelle PG, Maggard-Gibbons M, Girgis MD (2021) Comparison of clinical outcomes of robot-assisted, video-assisted, and open esophagectomy for esophageal cancer: a systematic review and meta-analysis. JAMA Netw Open 4:e2129228–e2129228CrossRefPubMedPubMedCentral Mederos MA, de Virgilio MJ, Shenoy R, Ye L, Toste PA, Mak SS, Booth MS, Begashaw MM, Wilson M, Gunnar W, Shekelle PG, Maggard-Gibbons M, Girgis MD (2021) Comparison of clinical outcomes of robot-assisted, video-assisted, and open esophagectomy for esophageal cancer: a systematic review and meta-analysis. JAMA Netw Open 4:e2129228–e2129228CrossRefPubMedPubMedCentral

go back to reference Rice TW, Patil DT, Blackstone EH (2017) 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg 6:119–130CrossRefPubMedPubMedCentral Rice TW, Patil DT, Blackstone EH (2017) 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg 6:119–130CrossRefPubMedPubMedCentral

go back to reference Daiko H, Nishimura M (2012) A pilot study of the technical and oncologic feasibility of thoracoscopic esophagectomy with extended lymph node dissection in the prone position for clinical stage I thoracic esophageal carcinoma. Surg Endosc 26:673–680CrossRefPubMed Daiko H, Nishimura M (2012) A pilot study of the technical and oncologic feasibility of thoracoscopic esophagectomy with extended lymph node dissection in the prone position for clinical stage I thoracic esophageal carcinoma. Surg Endosc 26:673–680CrossRefPubMed

go back to reference Fujiwara H, Kanamori J, Nakajima Y, Kawano T, Miura A, Fujita T, Akita K, Daiko H (2018) An anatomical hypothesis: a “concentric-structured model” for the theoretical understanding of the surgical anatomy in the upper mediastinum required for esophagectomy with radical mediastinal lymph node dissection. Dis Esophagus 32:119CrossRef Fujiwara H, Kanamori J, Nakajima Y, Kawano T, Miura A, Fujita T, Akita K, Daiko H (2018) An anatomical hypothesis: a “concentric-structured model” for the theoretical understanding of the surgical anatomy in the upper mediastinum required for esophagectomy with radical mediastinal lymph node dissection. Dis Esophagus 32:119CrossRef

go back to reference Hirano Y, Fujita T, Sato K, Kurita D, Sato T, Ishiyama K, Fujiwara H, Oguma J, Daiko H (2020) Totally mechanical collard technique for cervical esophagogastric anastomosis reduces stricture formation compared with circular stapled anastomosis. World J Surg 44:4175–4183CrossRefPubMed Hirano Y, Fujita T, Sato K, Kurita D, Sato T, Ishiyama K, Fujiwara H, Oguma J, Daiko H (2020) Totally mechanical collard technique for cervical esophagogastric anastomosis reduces stricture formation compared with circular stapled anastomosis. World J Surg 44:4175–4183CrossRefPubMed

go back to reference Daiko H, Fujita T (2015) Laparoscopic assisted versus open gastric pull-up following thoracoscopic esophagectomy: a cohort study. Int J Surg 19:61–66CrossRefPubMed Daiko H, Fujita T (2015) Laparoscopic assisted versus open gastric pull-up following thoracoscopic esophagectomy: a cohort study. Int J Surg 19:61–66CrossRefPubMed

go back to reference Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196CrossRefPubMed Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196CrossRefPubMed

go back to reference Torek F (1915) The operative treatment of carcinoma of the oesophagus. Ann Surg 61:385CrossRefPubMedPubMedCentral Torek F (1915) The operative treatment of carcinoma of the oesophagus. Ann Surg 61:385CrossRefPubMedPubMedCentral

go back to reference Akagawa S, Hosogi H, Yoshimura F, Kawada H, Kanaya S (2018) Mesenteric excision for esophageal cancer surgery: based on the concept of mesotracheoesophagus. Int Cancer Conf J 7:117–120CrossRefPubMedPubMedCentral Akagawa S, Hosogi H, Yoshimura F, Kawada H, Kanaya S (2018) Mesenteric excision for esophageal cancer surgery: based on the concept of mesotracheoesophagus. Int Cancer Conf J 7:117–120CrossRefPubMedPubMedCentral

go back to reference Cuesta MA, Weijs TJ, Bleys RL, van Hillegersberg R, van Berge Henegouwen MI, Gisbertz SS, Ruurda JP, Straatman J, Osugi H, van der Peet DL (2015) A new concept of the anatomy of the thoracic oesophagus: the meso-oesophagus. Observational study during thoracoscopic esophagectomy. Surg Endosc 29:2576–2582CrossRefPubMed Cuesta MA, Weijs TJ, Bleys RL, van Hillegersberg R, van Berge Henegouwen MI, Gisbertz SS, Ruurda JP, Straatman J, Osugi H, van der Peet DL (2015) A new concept of the anatomy of the thoracic oesophagus: the meso-oesophagus. Observational study during thoracoscopic esophagectomy. Surg Endosc 29:2576–2582CrossRefPubMed

go back to reference Talamini MA, Chapman S, Horgan S, Melvin WS (2003) A prospective analysis of 211 robotic-assisted surgical procedures. Surg Endosc Other Interv Tech 17:1521–1524 Talamini MA, Chapman S, Horgan S, Melvin WS (2003) A prospective analysis of 211 robotic-assisted surgical procedures. Surg Endosc Other Interv Tech 17:1521–1524

go back to reference Li XK, Xu Y, Zhou H, Cong ZZ, Wu WJ, Qiang Y, Shen Y (2021) Does robot-assisted minimally invasive oesophagectomy have superiority over thoraco-laparoscopic minimally invasive oesophagectomy in lymph node dissection? Dis Esophagus 34:doaa50CrossRef Li XK, Xu Y, Zhou H, Cong ZZ, Wu WJ, Qiang Y, Shen Y (2021) Does robot-assisted minimally invasive oesophagectomy have superiority over thoraco-laparoscopic minimally invasive oesophagectomy in lymph node dissection? Dis Esophagus 34:doaa50CrossRef

go back to reference Zheng C, Li XK, Zhang C, Zhou H, Ji SG, Zhong JH, Xu Y, Cong ZZ, Wang GM, Wu WJ, Shen Y (2021) Comparison of short-term clinical outcomes between robot-assisted minimally invasive esophagectomy and video-assisted minimally invasive esophagectomy: a systematic review and meta-analysis. J Thorac Dis 13:708–719CrossRefPubMedPubMedCentral Zheng C, Li XK, Zhang C, Zhou H, Ji SG, Zhong JH, Xu Y, Cong ZZ, Wang GM, Wu WJ, Shen Y (2021) Comparison of short-term clinical outcomes between robot-assisted minimally invasive esophagectomy and video-assisted minimally invasive esophagectomy: a systematic review and meta-analysis. J Thorac Dis 13:708–719CrossRefPubMedPubMedCentral

go back to reference Jin D, Yao L, Yu J, Liu R, Guo T, Yang K, Gou Y (2019) Robotic-assisted minimally invasive esophagectomy versus the conventional minimally invasive one: a meta-analysis and systematic review. Int J Med Robot Comput Assist Surg 15:e1988CrossRef Jin D, Yao L, Yu J, Liu R, Guo T, Yang K, Gou Y (2019) Robotic-assisted minimally invasive esophagectomy versus the conventional minimally invasive one: a meta-analysis and systematic review. Int J Med Robot Comput Assist Surg 15:e1988CrossRef

go back to reference Zhang Y, Dong D, Cao Y, Huang M, Li J, Zhang J, Lin J, Sarkaria IS, Toni L, David R, He J, Li H (2023) Robotic versus conventional minimally invasive esophagectomy for esophageal cancer: a meta-analysis. Ann Surg 278:39–50CrossRefPubMed Zhang Y, Dong D, Cao Y, Huang M, Li J, Zhang J, Lin J, Sarkaria IS, Toni L, David R, He J, Li H (2023) Robotic versus conventional minimally invasive esophagectomy for esophageal cancer: a meta-analysis. Ann Surg 278:39–50CrossRefPubMed

go back to reference Chao Y-K, Li Z-G, Wen Y-W, Kim D-J, Park S-Y, Chang Y-L, van der Sluis PC, Ruurda JP, van Hillegersberg R (2019) Robotic-assisted esophagectomy vs video-assisted thoracoscopic esophagectomy (REVATE): study protocol for a randomized controlled trial. Trials 20:346CrossRefPubMedPubMedCentral Chao Y-K, Li Z-G, Wen Y-W, Kim D-J, Park S-Y, Chang Y-L, van der Sluis PC, Ruurda JP, van Hillegersberg R (2019) Robotic-assisted esophagectomy vs video-assisted thoracoscopic esophagectomy (REVATE): study protocol for a randomized controlled trial. Trials 20:346CrossRefPubMedPubMedCentral

go back to reference Tagkalos E, van der Sluis PC, Berlth F, Poplawski A, Hadzijusufovic E, Lang H, van Berge Henegouwen MI, Gisbertz SS, Müller-Stich BP, Ruurda JP, Schiesser M, Schneider PM, van Hillegersberg R, Grimminger PP (2021) Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial). BMC Cancer 21:1060CrossRefPubMedPubMedCentral Tagkalos E, van der Sluis PC, Berlth F, Poplawski A, Hadzijusufovic E, Lang H, van Berge Henegouwen MI, Gisbertz SS, Müller-Stich BP, Ruurda JP, Schiesser M, Schneider PM, van Hillegersberg R, Grimminger PP (2021) Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial). BMC Cancer 21:1060CrossRefPubMedPubMedCentral

go back to reference Yang Y, Li B, Yi J, Hua R, Chen H, Tan L, Li H, He Y, Guo X, Sun Y, Yu B, Li Z (2022) Robot-assisted versus conventional minimally invasive esophagectomy for resectable esophageal squamous cell carcinoma: early results of a multicenter randomized controlled trial: the RAMIE trial. Ann Surg 275:646–653CrossRefPubMed Yang Y, Li B, Yi J, Hua R, Chen H, Tan L, Li H, He Y, Guo X, Sun Y, Yu B, Li Z (2022) Robot-assisted versus conventional minimally invasive esophagectomy for resectable esophageal squamous cell carcinoma: early results of a multicenter randomized controlled trial: the RAMIE trial. Ann Surg 275:646–653CrossRefPubMed

go back to reference Visser E, Markar SR, Ruurda JP, Hanna GB, van Hillegersberg R (2019) Prognostic value of lymph node yield on overall survival in esophageal cancer patients: a systematic review and meta-analysis. Ann Surg 269:261–268CrossRefPubMed Visser E, Markar SR, Ruurda JP, Hanna GB, van Hillegersberg R (2019) Prognostic value of lymph node yield on overall survival in esophageal cancer patients: a systematic review and meta-analysis. Ann Surg 269:261–268CrossRefPubMed

go back to reference Dudash MJ, Slipak S, Dove J, Hunsinger M, Wild J, Shabahang M, Arora TK, Blansfield JA (2019) Lymph node harvest as a measure of quality and effect on overall survival in esophageal cancer: a National Cancer Database Assessment. Am Surg™ 85:201–205CrossRefPubMed Dudash MJ, Slipak S, Dove J, Hunsinger M, Wild J, Shabahang M, Arora TK, Blansfield JA (2019) Lymph node harvest as a measure of quality and effect on overall survival in esophageal cancer: a National Cancer Database Assessment. Am Surg™ 85:201–205CrossRefPubMed

go back to reference Scholtemeijer MG, Seesing MFJ, Brenkman HJF, Janssen LM, van Hillegersberg R, Ruurda JP (2017) Recurrent laryngeal nerve injury after esophagectomy for esophageal cancer: incidence, management, and impact on short- and long-term outcomes. J Thorac Dis 9:S868-s878CrossRefPubMedPubMedCentral Scholtemeijer MG, Seesing MFJ, Brenkman HJF, Janssen LM, van Hillegersberg R, Ruurda JP (2017) Recurrent laryngeal nerve injury after esophagectomy for esophageal cancer: incidence, management, and impact on short- and long-term outcomes. J Thorac Dis 9:S868-s878CrossRefPubMedPubMedCentral

go back to reference Kanematsu K, Kudose Y, Utsunomiya D, Kubo K, Fujii Y, Kurita D, Ishiyama K, Oguma J, Daiko H (2022) Surveillance strategy after curative resection for oesophageal squamous cell carcinoma using the hazard function. BMC Cancer 22(1):1245CrossRefPubMedPubMedCentral Kanematsu K, Kudose Y, Utsunomiya D, Kubo K, Fujii Y, Kurita D, Ishiyama K, Oguma J, Daiko H (2022) Surveillance strategy after curative resection for oesophageal squamous cell carcinoma using the hazard function. BMC Cancer 22(1):1245CrossRefPubMedPubMedCentral